Although the liver cancer space currently lacks marketed treatments, with just two targeted therapies – Nexavar (sorafenib) and Stivarga (regorafenib) – which provide...

Partnership aimed at the development of molecular diagnostic assays on Biocartis' fully automated Idylla(TM) platform   London (UK) / Mechelen (Belgium), 7 June 2017 ...

Cold chain packaging leader shares knowledge and insight on supply chain compliance at key clinical trial supply event Peli BioThermal, the global name in cold chain,...

Porto, Portugal | Hatfield, UK | – Bial and Eisai today announce that the European Medicines Agency (EMA) has approved Zebinix® (eslicarbazepine acetate) for use as a...

WideCells Group PLC ('WideCells' or the 'Company'), the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cel...